H. Kodama

发表

Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans.

T. Ikenoue, K. Arimori, K. Yamasaki, 2003, Biological & pharmaceutical bulletin.

Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.

S. Shinozawa, H. Kodama, R. Kanemaru, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro.

K. Kawai, K. Arimori, K. Yamasaki, 2005, Biological & pharmaceutical bulletin.

Serum protein binding kinetics of phenytoin in monotherapy patients

Y. Mitsuyama, R. Kanemaru, S. Shinozawa, 1998, Journal of clinical pharmacy and therapeutics.

Change in Drug Concentration in Serum Stored in Sterilized Vacuum Tubes for Serum Separation

K. Arimori, K. Yamasaki, M. Okumura, 2005 .

Utilisation of Human Pharmacology Studies with Biomarkers for New Drug Applications in Japan

A. Fujimura, S. Ono, H. Kodama, 2005, Drugs in R&D.

Design and synthesis of peptidomimetic factor VIIa inhibitors.

S. Kadono, T. Shiraishi, Yoshiaki Watanabe, 2010, Chemical & pharmaceutical bulletin.

Inhibitory Effect of Tea Beverages on Human Cytochrome P 450 3A (CYP 3A) Activity

K. Arimori, K. Yamasaki, M. Okumura, 2006 .

Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.

S. Kadono, T. Shiraishi, Yoshiaki Watanabe, 2008, Bioorganic & medicinal chemistry letters.

Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.

S. Kadono, T. Shiraishi, Yoshiaki Watanabe, 2004, Biochemical and biophysical research communications.

Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.

Tsukasa Suzuki, S. Kadono, T. Shiraishi, 2005, Biochemical and Biophysical Research Communications - BBRC.

Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.

Tsukasa Suzuki, S. Kadono, T. Shiraishi, 2005, Biochemical and biophysical research communications.

Comparison of Equations for Predicting Bound Serum Concentrations of Carbamazepine and Carbamazepine‐10, 11‐epoxide After Polytherapy in Patients with Epilepsy

M. Takeyama, H. Kodama, K. Tsutsumi, 1995, Journal of clinical pharmacology.

Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity.

K. Arimori, K. Yamasaki, Ken-Ichi Fujita, 2004, Drug metabolism and disposition: the biological fate of chemicals.

Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.

A. Fujimura, E. Yukawa, H. Kodama, 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Mode of Interaction of Loop Diuretics with Human Serum Albumin and Characterization of Binding Site

M. Otagiri, K. Yamasaki, A. Suenaga, 1996, Pharmaceutical Research.

Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy.

M. Takeyama, H. Kodama, Y. Kodama, 1995, Journal of pharmaceutical sciences.

Evaluation on Disintegration Tests of Rapidly-Disintegrating Tablets.

K. Arimori, N. Takamura, K. Ogata, 2001 .

Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.

A. Fujimura, Takuhiro Yamaguchi, H. Kodama, 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy

S. Shinozawa, H. Kodama, R. Kanemaru, 2001, Journal of clinical pharmacy and therapeutics.

No Effect of Gender or Age on Binding Characteristics of Valproic Acid to Serum Proteins in Pediatric Patients with Epilepsy

A. Fujimura, H. Kodama, K. Tsutsumi, 1999, Journal of clinical pharmacology.

Comparison of Two Binding Equations for Prediction of the Concentration of Unbound Valproic Acid in the Serum of Adult Epileptic Polytherapy Patients

E. Yukawa, M. Takeyama, H. Kodama, 1996, The Journal of pharmacy and pharmacology.

No Gender Effect on Binding Characteristics of Phenytoin to Serum Proteins in Monotherapy for Adult Patients with Epilepsy

Y. Mitsuyama, R. Kanemaru, H. Kodama, 2000, American journal of therapeutics.

In Vivo Determinations of Carbamazepine and Carbamazepine‐10, 11‐epoxide Binding Parameters to Serum Proteins in Monotherapy Patients

M. Takeyama, H. Kodama, Y. Kodama, 1993, Journal of clinical pharmacology.

Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4.

S. Kadono, T. Shiraishi, Yoshiaki Watanabe, 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

Structure-Based Drug Design of Peptide Mimetics Containing Large P3 Moieties as Inhibitors of Factor VIIa

S. Kadono, T. Shiraishi, Yoshiaki Watanabe, 2009 .

Evaluation of Quality of Arotinolol Hydrochloride Tablets-Comparison between Branded and Generic Products-

K. Arimori, K. Yamasaki, M. Okumura, 2006 .